KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $887.9 million.

  • Idexx Laboratories' Net Income towards Common Stockholders rose 17.94% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 18.61%. This contributed to the annual value of $887.9 million for FY2024, which is 5.07% up from last year.
  • According to the latest figures from FY2024, Idexx Laboratories' Net Income towards Common Stockholders is $887.9 million, which was up 5.07% from $845.0 million recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Net Income towards Common Stockholders registered a high of $887.9 million during FY2024, and its lowest value of $581.4 million during FY2020.
  • For the 3-year period, Idexx Laboratories' Net Income towards Common Stockholders averaged around $804.0 million, with its median value being $845.0 million (2023).
  • In the last 5 years, Idexx Laboratories' Net Income towards Common Stockholders spiked by 36.02% in 2020 and then declined by 8.83% in 2022.
  • Yearly analysis of 5 years shows Idexx Laboratories' Net Income towards Common Stockholders stood at $581.4 million in 2020, then rose by 28.11% to $744.8 million in 2021, then decreased by 8.83% to $679.1 million in 2022, then grew by 24.44% to $845.0 million in 2023, then climbed by 5.07% to $887.9 million in 2024.